Companies / Prelude Therapeutics Incorporated / Activity
Activity — Prelude Therapeutics Incorporated
2 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $148.3K | +28K | 27,824 0.03% of shares | low |
| Q1 2026 as of | Graham Capital Management, L.P. 13F manager | New | Common stock | $38.8K | +11K | 11,343 0.01% of shares | low |